Breaking News Instant updates and real-time market news.

DEPO

DEPO

06:12
08/08/17
08/08
06:12
08/08/17
06:12

Depomed downgraded to Neutral from Buy at Janney Capital

DEPO DEPO

04/10/17
JANY
04/10/17
NO CHANGE
Target $26
JANY
Buy
Depomed has high odds of success in patent suit with Purdue, says Janney Capital
Janney Capital analyst Ken Trbovich attributed a roughly 15% rally in Depomed shares on Friday to a Markman ruling in the company's patent infringement suit against Purdue Pharma. Historical PricewaterhouseCoopers data from such suits suggests Depomed has "very high odds of success," said Trbovich, who added that the company has sought a jury trial as opposed to bench trial, in which the odds of the patent holder prevailing go up significantly. The elements of the fight significantly increase Depomed's bargaining power in negotiations for a settlement, adds the analyst, who has a Buy rating and $26 fair value estimate on Depomed shares.
05/10/17
PIPR
05/10/17
UPGRADE
Target $10
PIPR
Neutral
Depomed upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst David Amsellem upgraded Depomed to Neutral saying the multiple is now more appropriate following the post-earnings selloff. The analyst lowered his price target for the shares to $10 from $11.
05/10/17
05/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Buy from Neutral at Goldman Sachs and to Market Perform from Underperform at Wells Fargo. 2. Coach (COH) upgraded to Buy from Neutral at Goldman Sachs with analyst Lindsay Drucker Mann saying after its acquisition of Kate Spade (KATE), Coach will be a "relative winner in handbags." 3. Lumber Liquidators (LL) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying that the company has stabilized and is poised to return to growth. 4. Occidental Petroleum (OXY) upgraded to Neutral from Underweight at JPMorgan with analyst Phil Gresh citing valuation with the shares. 5. Depomed (DEPO) upgraded to Neutral from Underweight at Piper Jaffray with analyst David Amsellem saying the multiple is now more appropriate following the post-earnings selloff. The analyst lowered his price target for the shares to $10 from $11. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/17
ROTH
05/17/17
NO CHANGE
Target $16
ROTH
Buy
Depomed target lowered on 'deteriorating' opioid environment at Roth Capital
Roth Capital analyst Scott Henry lowered his price target for Depomed to $16 from $18 citing a "deteriorating macro environment" for opioid pain treatments. The analyst, however, views Depomed as a winner when the opioid market stabilizes, which he expects in mid-2018. Henry keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

STL

Sterling Bancorp

$17.19

-0.63 (-3.54%)

08:42
12/11/18
12/11
08:42
12/11/18
08:42
Conference/Events
Sterling Bancorp management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SMTC

Semtech

$46.80

0.05 (0.11%)

08:41
12/11/18
12/11
08:41
12/11/18
08:41
Conference/Events
Semtech management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

RMAX

RE/MAX Holdings

$30.66

-0.14 (-0.45%)

08:40
12/11/18
12/11
08:40
12/11/18
08:40
Conference/Events
RE/MAX Holdings management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HR

Healthcare Realty Trust

$31.09

-0.57 (-1.80%)

08:40
12/11/18
12/11
08:40
12/11/18
08:40
Downgrade
Healthcare Realty Trust rating change  »

Healthcare Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPER

Xperi

$18.39

5.59 (43.67%)

08:40
12/11/18
12/11
08:40
12/11/18
08:40
Recommendations
Xperi analyst commentary  »

Xperi price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

08:40
12/11/18
12/11
08:40
12/11/18
08:40
General news
U.S. final demand PPI rose 0.1% in November, with the core component 0.3% higher »

U.S. final demand PPI…

08:40
12/11/18
12/11
08:40
12/11/18
08:40
General news
Breaking General news story  »

Week of 12/8 Redbook to…

08:39
12/11/18
12/11
08:39
12/11/18
08:39
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

QLYS

Qualys

$77.65

1.99 (2.63%)

08:39
12/11/18
12/11
08:39
12/11/18
08:39
Conference/Events
Qualys management to meet with JMP Securities »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 19

    Dec

  • 09

    Jan

UNFI

United Natural Foods

$13.67

-1.18 (-7.95%)

08:38
12/11/18
12/11
08:38
12/11/18
08:38
Upgrade
United Natural Foods rating change  »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$28.14

-0.445 (-1.56%)

08:37
12/11/18
12/11
08:37
12/11/18
08:37
Hot Stocks
Aecom reiterates long-term financial targets through FY22 »

AECOM will hold its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MPW

Medical Properties Trust

08:37
12/11/18
12/11
08:37
12/11/18
08:37
Upgrade
Medical Properties Trust rating change  »

Medical Properties Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAY

Dave & Buster's

$52.52

-0.54 (-1.02%)

08:36
12/11/18
12/11
08:36
12/11/18
08:36
Recommendations
Dave & Buster's analyst commentary  »

Dave & Buster's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 14

    Dec

ELTK

Eltek

$3.05

(0.00%)

08:35
12/11/18
12/11
08:35
12/11/18
08:35
Hot Stocks
Eltek receives not in compliance letter from NASDAQ »

Eltek announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

, POL

PolyOne

$30.74

-0.24 (-0.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cooper-Standard licenses Fortrex material platform to PolyOne Corp. »

Cooper Standard (CPS) has…

CPS

Cooper-Standard

$66.48

-0.67 (-1.00%)

POL

PolyOne

$30.74

-0.24 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.20

0.08 (3.77%)

08:34
12/11/18
12/11
08:34
12/11/18
08:34
Hot Stocks
Cellectar Biosciences granted Japanese patent for CLR 131 »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$1.35

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Conference/Events
Viveve Medical to hold a webinar »

Webinar entitled,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TRPX

Therapix Biosciences

$5.33

(0.00%)

08:33
12/11/18
12/11
08:33
12/11/18
08:33
Hot Stocks
Therapix Biosciences provided update regarding LOI with FSD »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESQ

Esquire Financial

$24.00

0.27 (1.14%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Hot Stocks
Esquire Financial names Eric Bader as COO, Michael Lacapria as CFO »

Esquire Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$14.61

-1.28 (-8.06%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Downgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

WELL

Welltower

$73.07

-0.66 (-0.90%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Upgrade
Welltower rating change  »

Welltower upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

, VSAT

ViaSat

$65.44

-0.01 (-0.02%)

08:32
12/11/18
12/11
08:32
12/11/18
08:32
Conference/Events
Morgan Stanley to hold a summit »

Space Summit to be held…

MAXR

Maxar Technologies

$13.58

-0.535 (-3.79%)

VSAT

ViaSat

$65.44

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

ONCS

OncoSec

$0.87

0.0553 (6.79%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Hot Stocks
OncoSec announces new data on treatment with TAVO »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Jefferies to hold a summit »

Office & Industrial…

PWR

Quanta Services

$30.72

-0.6 (-1.92%)

08:31
12/11/18
12/11
08:31
12/11/18
08:31
Conference/Events
Quanta Services management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.